Bulgarian drug maker Sopharma sells 75% of Extab Corp

Neither the price of the deal, nor the buyer were disclosed.

Following the transaction, Sopharma retains a 5% stake in Extab, it said in a bourse filing on Tuesday.

Extab Corporation, based in the state of Delaware, was set up in November 2008. Shortly after, Sopharma entered its shareholding structure.

In May 2013, Sopharma announced its intentions to sell share in Extab sayng that it will ensure the extra resources needed for the development of proprietary drugs on new markets.